In the charge sheet, filed by ED's Special Public Prosecutor Nitesh Rana, the probe agency has accused all three of money laundering, punishable under sections 3 and 4 of the Prevention of Money Laundering Act.
ED on January 10 filed a charge sheet against Shivinder Singh and his brother Malvinder before a Delhi court in a case related to alleged misappropriation of funds at Religare Finvest Ltd.
A duty magistrate sent both the accused to the Enforcement Directorate's custody in a proceeding held at the Tihar central jail due to an ongoing strike by lawyers in district courts.
The Enforcement Directorate (ED) took both the accused in its custody inside the Tihar central jail here, where they are currently lodged in a case filed by the Delhi Police in relation to the alleged scam, a lawyer associated with the case said.
Investigating agencies have a task at hand to find out the money trail -- where it had flown and who were the end beneficiaries
Sebi, in an ad interim ex-parte order of October 17, 2018, had directed that FHL take necessary steps to recover Rs 403 crore along with interest from the Singh brothers and various promoter companies within three months.
The top court asked the Singh brothers to consult their accountants as also financial and legal advisors and apprise it by March 28.
The other people who are named in the complaint include Gurkirat Singh Dhillon, Gurpreet Singh Dillon, Shabnam Dhillon, Godhwani kin - Sunil and Sanjay.
The proposed open offer is scheduled to be launched from December 18 to January 1, 2019.
Shivinder had earlier on September 4 filed a case against Malvinder and Sunil Godhwani in the NCLT, alleging 'oppression and mismanagement' of RHC Holding, Religare Enterprises and Fortis Healthcare.
IHH's valuation tops the other two offers that Fortis got from Manipal-TPG consortium and a joint bid from Munjal (Hero) and the Burmans (Dabur).
Fortis Healthcare's Malvinder Singh and Shivinder Singh referred as Singh brothers, have also promised of their support to the management and Board for the successful transition.
The court directed them to submit list of unencumbered personal assets that need to be valued.
Analysts say Fortis is fast reaching a point of make or break. Only a deep pocketed strategic investor could salvage the company.
In a bid to tide over cash crunch at the group level, Malvinder Singh and Shivinder Singh are looking to divest majority stake in Fortis Healthcare, Religare Health Insurance, Religare Securities and eventually in Religare Enterprises, The Economic Times reported Saturday.
Following last year's failed attempts by Malvinder Singh and Shivinder Singh to sell stake in financial services group Religare Enterprise of which they are promoters, the brothers are reportedly in talks to sell Religare Invest, according to a story in The Economic Times.
Malvinder Singh and Shivinder Singh have been planning to offload their entire holding or a minimum 51 percent stake in the company. As of June 2015, the promoters hold 50.93 percent in Religare.
The company said that J P Morgan and Religare Capital Markets acted as financial advisors to Fortis for the transaction.
"The divestment enables Fortis to further strengthen balance sheet and substantially improve net debt equity ratio, creating further room for growth," Malvinder Singh, executive chairman, and Shivinder Singh, executive vice chairman of Fortis Healthcare said.
By selling global assets, Fortis is cutting losses but does that justify the method in its acquisition madness?
The transaction is part of a plan by Religare's founders, billionaire brothers Malvinder and Shivinder Singh, to bring down their holding to 49 percent in order to qualify for a banking licence in India.
Fortis Healthcare shares rose over 7 percent on Monday after the company said it was selling its 64 percent stake in Australia's Dental Corp Holdings to British medical services group Bupa for 270 million Australian dollars.
Fortis Healthcare announced to divest 64 per cent stake in Dental Corporation Holdings (DC), Australia. The company's stake in DC will be sold to Bupa for 270 million Australian dollar (around Rs 1,554.36 crore) by March 2013.
The billionaire life brings with it many perks, but none so much as artâ€”its appreciation and acquisitionâ€”which sets one extraordinarily rich scion apart from the other.
Billionaires Malvinder and Shivinder are relentless in their efforts to make Fortis Healthcare a global player. Will they succeed?